Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00617019 · ClinicalTrials.gov registry record
Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)
A clinical trial of Parkinson Disease, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 3,234
- Enrollment target
- 20
- Study locations
NCT00617019: Completed study of Parkinson Disease, sponsored by Boehringer Ingelheim.
NCT00617019 is a study of Parkinson Disease that has completed, run by Boehringer Ingelheim. The registered enrollment target is 3,234 participants, below the 5,316-participant average among 297 other Parkinson Disease trials with a reported enrollment target (39% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00617019, a study of Parkinson Disease, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 3,234 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
Conditions Studied
Study Locations (20)
California
- 248.619.01018 Margolin Brain Institute - Fresno
- 248.619.01031 Pacific Neuroscience Medical Group, Inc. - Oxnard
- 248.619.01016 San Francisco VA PD Research, Education, & Clinical Center - San Francisco
- 248.619.01023 The Parkinson's Institute - Sunnyvale
Arizona
- 248.619.01034 Neurological Physicians of Arizona - Gilbert
- 248.619.01007 Mayo Clinic - Scottsdale - Scottsdale
- 248.619.01025 Sun Health Research Institute - Sun City
Connecticut
- 248.619.01027 Associated Neurologists, P.C. - Danbury
- 248.619.01013 Molecular NeuroImaging - New Haven
Florida
- 248.619.01020 Parkinson's Disease and Movement Disorders of Boca Raton - Boca Raton
- 248.619.01009 University of Florida - Gainesville
Georgia
- 248.619.01035 Emory University - Atlanta
- 248.619.01006 Medical College of Georgia - Augusta
Colorado
- 248.619.01021 Boehringer Ingelheim Investigational Site - Englewood
Illinois
- 248.619.01014 Northwestern University - Chicago
Kansas
- 248.619.01001 The University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,234 participants |
| Start Date | 2006-09 |
What the finished NCT00617019 record still lists
NCT00617019 is an observational study that tracks outcomes without assigning an intervention. Its 3,234 participants enrollment target places it among the larger protocols in the corpus, below the 5,316-participant average among 297 other Parkinson Disease trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00617019 names 20 study sites across 12 states, led by California, Arizona, Connecticut.
Frequently Asked Questions
What is clinical trial NCT00617019 about?
NCT00617019 is a clinical study titled "Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)". The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
What is the current status of trial NCT00617019?
This trial is currently completed. The enrollment target is 3,234 participants. The study started on 2006-09.
What conditions does trial NCT00617019 study?
This clinical trial studies the following conditions: Parkinson Disease.
Who is sponsoring clinical trial NCT00617019?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00617019 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00617019's enrollment target sits among peer trials
3,234 7th of 297 higher than 291 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06953375 · 3,250 participants · NA
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
- NCT06587529 · 3,218 participants · NA
Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children
- NCT06760507 · 3,209 participants · NA
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
- NCT04077762 · 3,266 participants · NA
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia